NCT01603251View on ClinicalTrials.gov

Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Malaria
Interventions
DRUG

Artemether-lumefantrine combination

Artemether-Lumefantrine (AL)combination; a placebo is given together with the first and fifth dose of AL

DRUG

Artemether-lumefantrine combination + single dose Ivermectin

Artemether-lumefantrine (AL) combination + Ivermectin (200ug/kg) given once together with the first dose of AL. A placebo is given together with the fifth dose of AL.

DRUG

Artemether-lumefantrine combination + repeated dose Ivermectin

Artemether-lumefantrine (AL) combination + Ivermectin (200ug/kg) given together with the first and fifth dose of AL.

Trial Locations (1)

Unknown

Centre National de Recherche et de Formation sur le Paludisme, Ouagadougou

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

collaborator

Centre national de recherche et de formation sur le paludisme

OTHER_GOV

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT01603251 - Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission | Biotech Hunter | Biotech Hunter